about
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making ...
Read More
40.79
2.90
(7.65%)
771.3K
XNAS Volume
XNAS 14 Nov, 2025 4:30 PM (EST)
Board Meeting
The board meeting for Harrow Health Inc is scheduled for today, for the purpose of Harrow Inc Third Quarter Earnings Conference Call for 2025
See details
Medium Financial Strength
Expensive Valuation
Technically Moderately Bullish
Expensive Rocket
These stocks are a favourite among investors due to their bullish nature, good technical aspects but they have bad valuation and medium financials.
View Similar
Embed DVM
Harrow Health Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..